Global Human Growth Hormone Market Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 6.8% - ResearchAndMarkets.com

August 3, 2018

DUBLIN--(BUSINESS WIRE)--Aug 3, 2018--The “Global Human Growth Hormone Market - Segmented by Application, Distribution Channel, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global human growth hormone market is expected to register a CAGR of 6.8% during the forecast period, 2018 to 2023.

The pituitary gland produces hormones that the affect growth and functionality of the other glands. It plays an important role in the physical growth of children. Growth Hormones levels rise gradually during childhood and peak during puberty. The dysfunction of pituitary may lead to the abnormal physical growth. According to the estimates of American Society of Clinical Oncology (ASCO) in the United States, 14,230 pituitary gland tumors were diagnosed in 2017.

The side effects of this hormone may affect adults more than the younger population. Side effects associated with the use of human growth hormones, such as nerve, muscle, or joint pain, swelling of the arms and legs from fluid retention, growth of facial features, hands, and feet, may hamper the growth of the human growth hormone market over the forecast period. Long-term effects of human growth hormone are unknown.

North America dominates the global human growth hormone market. The dominance of the region can be attributed to factors, such as high healthcare expenditure and commercialization of growth hormone by US Food and Drugs Administration (FDA) since last few years. In the United States, approximately 50,000 adults have growth hormone deficiency. Also, about 6,000 new adult patients diagnosed every year.

Companies Mentioned

AnkeBio Co. Ltd EMD Serono Inc. F. Hoffmann-La Roche Ferring BV Genentech Inc. Ipsen Lilly USA LLC Novo Nordisk A/S Pfizer Inc. Teva Pharmaceutical Industries Ltd

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/dp4pbc/global_human?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180803005344/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrine and Metabolic Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/03/2018 10:43 AM/DISC: 08/03/2018 10:42 AM


Update hourly